Venatorx Pharmaceuticals Inc.

Plus: Barbara Handelin named co-CEO of Transformative Biotech, and updates from Zephyr AI, Venatorx, Glen Clova and more

Plus: new COO for radiopharma 

An approval for Iovance’s lifileucel would mark the entry of immune cell therapies into solid tumors

Plus: new chair at Venatorx, and updates from VarmX and Nutcracker

Plus: Mestag names Logtenberg as chair and updates from Edgewise, Myriad and Venatorx

Partnership kick-starts AMR innovation, but progress on U.S. pull incentives awaits Congressional action 

Fund educating policymakers regarding the challenges faced by antibiotic developers

Plus AbbVie, Venatorx meet in Phase III and updates from MorphoSys, RefleXion, TG Therapeutics, Xeris and more

Plus: Mutamba joins Arrakis as CBO and updates from Goldfinch, Kymera, AnHeart and more

Plus Antios raises, Novo Nordisk misses, GRObio, Prilenia and more